Health-related quality of life of patients with type 2 diabetes mellitus in primary care in Spain: Self-reported and proxy assessment using the EQ-5D

Journal of Medical Economics

Volumn 10, Issue 1, 2007, Pages 41-58

  Boye, Kristina S ^a   Yurgin, Nicole ^a   Dilla, Tatiana ^b   Cordero, Luis A ^b   Badia, Xavier ^c   Suriñach, Nuria Lara ^c   Pérez, Pilar ^c  

^a ELI LILLY AND COMPANY   (United States)

^b ELI LILLY AND COMPANY   (Spain)

^c IQVIA   (United States)

Author keywords

EQ 5D; Health related quality of life; HRQoL; Proxy; Spain; Type 2 diabetes mellitus

Indexed keywords

INSULIN; METFORMIN; SULFONYLUREA;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; COST BENEFIT ANALYSIS; DATA ANALYSIS; DEMOGRAPHY; DIABETES MELLITUS; DIET THERAPY; EDUCATION; FEMALE; FOOT ULCER; HEALTH CARE SYSTEM; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PHYSICIAN; PREVALENCE; PRIMARY HEALTH CARE; QUALITY OF LIFE; RETINOPATHY; SCORING SYSTEM; SELF REPORT; SOCIOECONOMICS; SPAIN; UNIVARIATE ANALYSIS;

EID: 34147187807     PISSN: 13696998     EISSN: None     Source Type: Journal    
DOI: 10.3111/200710041058     Document Type: Article

References (44)

1. Benito LP, García MR, Puig DM et al; MIDIA. [Pathological characteristics of patients with diabetes mellitus type 2, in Spanish primary care.] Revista Clínica Española 2004; 204: 18-24 [in Spanish].
2. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-1431.
3. Ruíz-Ramos M, Escolar-Pujolar A, Mayoral SE et al. Diabetes mellitus in Spain: death rates, prevalence, impact costs and inequalities. Gaceta Sanitaria 2006; 20 (Suppl. 1): 15-24.
4. Mata Cases M, Cos Claramunt X, Bobé Molina I et al. [Type 2 diabetes mellitus: incidence and diagnosis at a primary care center.] Atencion Primaria 2000; 25: 469-474 [in Spanish].
5. Valverde JC, Tormo MK, Navarro C et al. Prevalence of diabetes in Murcia (Spain): a Mediterranean area characterised by obesity. Diabetes Research and Clinical Practice 2006; 71: 202-209.
6. Boronat M, Vrillas VF, Saavedra P et al. Diabetes mellitus and impaired glucose regulation in the Canary Islands (Spain): prevalence and associated factors in the adult population of Telde, Gran Canaria. Diabetic Medicine 2006; 23: 148-155.
7. Larranaga I, Arteagoitia JM, Rodriguez JL et al; the Sentinel Practice Network of the Basque Country. Socio-economic inequalities in the prevalence of type 2 diabetes, cardiovascular risk factors and chronic diabetic complications in the Basque Country, Spain. Diabetic Medicine 2005; 22: 1047-1053.
8. Masia R, Sala J, Rohlfs I et al; Investigadores del estudio REGICOR. Prevalence of diabetes mellitus in the province of Girona, Spain: the REGICOR study. Revista Española de Cardiología 2004; 57: 261-264.
9. Marks L; King's Fund Policy Institute. Counting the Cost. The real impact of non-insulin dependent diabetes. London, UK: British Diabetic Association, 1997.
10. Oliva J, Lobo F, Molina B et al. Direct health care costs of diabetic patients in Spain. Diabetes Care 2004; 27: 2616-2621.
11. Perales Céspedes MP, Martín Almendra MA. Papel de Atención Primaria en las complicaciones crónicas de la diabetes. Semergen 2005; 31: 265-269.
12. Glasgow RE, Ruggiero L, Eakin EG et al. Quality of life and associated characteristics in a large national sample of adults with diabetes. Diabetes Care 1997; 20: 562-567.
13. Lloyd A, Sawyer W, Hopkinson P. Impact of long-term complications on quality of life in patients with type 2 diabetes not using insulin. Value in Health 2001; 4: 392-400.
14. Luscombe FA. Health-related quality of life measurement in type 2 diabetes. Value in Health 2000; 3 (Suppl. 1): 15-28.
15. Bradley C, Todd C, Gorton T et al. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Quality of Life Research 1999; 8: 79-91.
16. Reviriego J, Millan MD, Millan M. Evaluation of the diabetes quality-of-life questionnaire in a Spanish population. An experience of translation and reliability. PharmacoEconomics 1996; 10: 614-622.
17. Welch GW, Jacobson AM, Polonsky WH. The Problem Areas in Diabetes Scale. An evaluation of its clinical utility. Diabetes Care 1997; 20: 760-766.
18. Fitzpatrick R, Davey C, Buxton MJ et al. Evaluating patient-based outcome measures for use in clinical trials. Health Technology Assessment 1998; 2: 1-74.
19. Hill-Briggs F, Gary TL, Hill MN et al. Health-related qualify of life in urban African Americans with type 2 diabetes. Journal of General Internal Medicine 2002; 17: 412-419.
20. Wee HL, Cheung YB, Li SC et al. The impact of diabetes mellitus and other chronic medical conditions on health-related quality of life: is the whole greater than the sum of its parts? Health and Quality of Life Outcomes 2005; 3: 2.
21. Thommasen HV, Berkowitz J, Thommasen AT et al. Understanding relationships between diabetes mellitus and health-related quality of life in a rural community. Rural and Remote Health 2005; 5: 441.
22. Wexler DJ, Grant RW, Wittenberg E et al. Correlated of health-related quality of life in type 2 diabetes. Diabetologia 2006; 49: 1489-1497.
23. Holmes J, McGill S, Kind P et al. Health-related quality of life in type 2 diabetes (TARDIS-2). Value in Health 2000; 3 (Suppl. 1): 47-51.
24. Sakamaki H, Ikeda S, Ikegami N et al. Measurement of HRQL using EQ-5D in patients with type 2 diabetes mellitus in Japan. Value in Health 2006; 9: 47-53.
25. Mata CM, Roset GM, Badia LX et al. Effect of type 2 diabetes mellitus on the quality of life of patients treated at primary care consultations in Spain. Atencion Primaria 2003; 31: 493-499.
26. The Medical Research Council Cognitive Function and Ageing Study. Survey into health problems of elderly people: a comparison of self-report with proxy information. International Journal of Epidemiology 2000; 29: 684-697.
27. Slevin ML, Plant H, Lynch D et al. Who should measure quality of life, the doctor or the patient? British Journal of Cancer 1988; 57: 109-112.
28. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2005; 28 (Suppl. 1): S37-S42.
29. Badia X, Roset M, Montserrat S et al. [The Spanish version of EuroQol: a description and its applications. European Quality of Life scale.] Medicina Clínica 1999; 112(Suppl. 1): 79-85.
30. Badia X, Roset M, Herdman M et al. A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Medical Decision Making 2001; 21: 7-16.
31. Portney L, Watkins M. Foundations of Clinical Research: applications to practice. Norwalk, CT: Appleton & Lange, 1993.
32. Lee J, Koh D, Ong CN. Statistical evaluation of agreement between two methods for measuring quantitative variables. Computers in Biology and Medicine 1989; 10: 61-70.
33. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQoL group. Annals of Medicine 2001; 33: 337-343.
34. Bagust A, Beale S. Modelling EuroQoL health-related utility values for diabetic complications from CODE-2 data. Health Economics 2005; 14: 217-230.
35. UK Prospective Diabetes Study Group. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care 1999; 22: 1125-1136.
36. Ragnarson Tennvall G, Apelqvist J. Health-related quality of life in patients with diabetes mellitus and foot ulcers. Journal of Diabetes and its Complications 2000; 14: 235-241.
37. Mata M, Antoñanzas F, Tafalla M et al. The cost of type 2 diabetes in Spain. The CODE-2 study. Gaceta Sanitaria 2002; 16: 511-520.
38. Sach TH, Barton GR, Doherty M et al. The relationship between body mass index and health related quality of life: comparing the EQ-5D, EuroQoL VAS and SF-6D. International Journal of Obesity 2006 May 9 [Epub ahead of print].
39. Pickard AS, Johnson JA, Feeny DH et al. Agreement between patient and proxy assessment of health-related quality of life after stroke using the EQ-5D and Health Utilities Index. Stroke 2004; 35: 607-612.
40. Wu AW, Jacobson DL, Berzon RA et al. The effect of mode of administration on medical outcomes study health ratings and EuroQoL scores in AIDS. Quality of Life Research 1997; 6: 3-10.
41. Sprangers MAG, Aaronson NK. The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: a review. Journal of Clinical Epidemiology 1992; 45: 743-760.
42. Nerenz DR, Repasky DP, Whitehouse FW et al. Ongoing assessment of health status in patients with diabetes mellitus. Medical Care 1992; 30 (Suppl. 5): MS112-124.
43. Dorman PJ, Waddell F, Slattery J et al. Are proxy assessments of health status after stroke with the EuroQol questionnaire feasible, accurate and unbiased? Stroke 1997; 28: 1883-1887.
44. Tamim H, McCusker J, Dendukuri N. Proxy reporting of quality of life using the EQ-5D. Medical Care 2002; 40: 1186-1195.